We are inviting adults with type 2 diabetes to take part in this study which aims to evaluate a potential new treatment designed to reduce blood glucose levels and body weight in people with type 2 diabetes.
Study completed
HREC ethics approval number 2023.232
The research project will compare the changes in blood sugar seen in people who take NNC0519-0130, the new treatment, and those who take a placebo or another type 2 diabetes medicine.
This study is no longer recruiting participants.